Abstract
Jur Strobos and colleagues describe the deliberations of a recent multi-stakeholder meeting discussing the creation of a sustainable global pharmacovigilance system for antiretroviral drugs that would be applicable in resource limited settings.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adverse Drug Reaction Reporting Systems / organization & administration*
-
Anti-Retroviral Agents / pharmacology
-
Anti-Retroviral Agents / standards*
-
Confidentiality
-
Delivery of Health Care / organization & administration
-
Drug Industry / organization & administration*
-
Humans
-
Insurance, Health / organization & administration
-
International Cooperation
-
Product Surveillance, Postmarketing